Breaking News

Societal CDMO Initiates New Fill/Finish and Lyo Project at San Diego Facility

To support a client's ongoing clinical development of a compound as a potential treatment for solid tumors.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Societal CDMO, Inc. announced a new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility.  The recently initiated project is focused on formulation development and sterile GMP manufacturing of a lyophilized novel cancer therapeutic for intravenous infusion. Societal has been contracted by an emerging Japan-based biopharmaceutical company to support the company’s ongoing clinical development of the compound as a potential treatment ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters